Moderate FKBP12.6 overexpression mitigates β-adrenergic-associated pro-arrhythmogenic Ca2+ events, but a higher expression level leads to a cardiomyopathic phenotype
| Autor: | Gandon-Renard, M., Lefebvre, F., Gomez, S., Courilleau, D., Journé, C., Benitah, J.P., Gomez, A.M., Mercadier, J.J. |
|---|---|
| Zdroj: | In Archives of Cardiovascular Diseases Supplements October 2020 12(2-4):253-253 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect